Introduction The effectiveness of corticosteroid therapy on the mortality of acute respiratory
distress syndrome (ARDS) remains under debate. We aimed to explore the grounds for the …

Background The possible benefits associated with corticosteroid treatment in acute
respiratory distress syndrome (ARDS) patients are not fully known. We conducted an …

Background The effect of corticosteroids on clinical outcomes in patients with influenza
pneumonia remains controversial. We aimed to further evaluate the influence of …

Background Authors of recent meta-analyses have reported that prolonged glucocorticoid
treatment is associated with significant improvements in patients with severe pneumonia or …

Objective: Controversy remains as to whether low-dose corticosteroids can reduce the
mortality and morbidity of acute lung injury (ALI) or the acute respiratory distress syndrome …

ABSTRACT INTRODUCTION Acute respiratory distress syndrome (ARDS) is a rapidly
progressing, inflammatory lung disease with a high mortality rate and no specific …

Introduction Current low (stress) dose corticosteroid regimens may have therapeutic
advantage in severe sepsis and septic shock despite conflicting results from two landmark …

Objective The impact of corticosteroids on acute respiratory distress syndrome (ARDS)
mortality remains controversial following the publication of numerous trials, observational …

Background Patients with 2009 pandemic influenza A (H1N1pdm09)-related critical illness
were frequently treated with systemic corticosteroids. While observational studies have …

Background Multiple corticosteroids and treatment regimens have been used as adjuncts in
the treatment of septic shock. Qualitative and quantitative differences exist at cellular and …